Natriumbenzylpenicilline Sandoz (Benzylpenicillin Sodium)

Benzylpenicillin Sodium, the active ingredient in Natriumbenzylpenicilline Sandoz, is a penicillin (beta‑lactam antibiotic) presented as a sterile solution for intraarticular, intramuscular and intrathecal use. It treats a range of bacterial infections in patients requiring parenteral therapy. It is indicated for severe infections caused by susceptible organisms. The product complies with EU regulatory standards for parenteral antibiotics. It is widely used in clinical practice across Europe.

GNH USA supplies Natriumbenzylpenicilline Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies, clinics and research institutions worldwide.

Benzylpenicillin Sodium is used to treat bacterial infections by targeting susceptible organisms in various clinical settings.

- Severe bacterial infections: provides rapid bactericidal activity against Gram‑positive and selected Gram‑negative pathogens. - Meningitis: achieves therapeutic concentrations in cerebrospinal fluid when administered intrathecally. - Surgical prophylaxis: prevents postoperative infections when given intra‑articularly or intramuscularly before surgery.

Benzylpenicillin Sodium may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort at the site of administration. - Local erythema: redness around the injection area. - Transient fever: short‑lasting elevation of body temperature. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Severe neutropenia: marked reduction in white blood cells. - Clostridioides difficile‑associated diarrhea: colitis caused by bacterial overgrowth. - Serum sickness–like reaction: fever, rash, arthralgia occurring days after exposure.

Before using Benzylpenicillin Sodium, clinicians should consider several precautionary measures to ensure safe administration.

- Allergy assessment: verify no history of penicillin hypersensitivity. - Renal function: adjust dosage in patients with severe renal impairment. - Pregnancy: use only when the potential benefit justifies the potential risk to the fetus. - Concurrent antibiotics: avoid simultaneous use with bacteriostatic agents that may antagonize its effect. - Monitoring: observe patients for signs of hypersensitivity during and after injection. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Benzylpenicillin Sodium can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Methotrexate: increased toxicity due to reduced renal clearance. - Oral contraceptives: decreased hormonal efficacy, raising risk of unintended pregnancy. - Probenecid: decreases renal excretion of penicillin, leading to higher plasma concentrations.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxic potential. - Warfarin: possible alteration of INR and bleeding risk. - Tetracyclines: antagonistic effect reducing bactericidal activity.